JP2008514722A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008514722A5 JP2008514722A5 JP2007534782A JP2007534782A JP2008514722A5 JP 2008514722 A5 JP2008514722 A5 JP 2008514722A5 JP 2007534782 A JP2007534782 A JP 2007534782A JP 2007534782 A JP2007534782 A JP 2007534782A JP 2008514722 A5 JP2008514722 A5 JP 2008514722A5
- Authority
- JP
- Japan
- Prior art keywords
- atorvastatin calcium
- amorphous atorvastatin
- amorphous
- drying
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61457804P | 2004-09-30 | 2004-09-30 | |
| IN715CH2005 | 2005-06-10 | ||
| PCT/US2005/035094 WO2006039441A2 (en) | 2004-09-30 | 2005-09-29 | Amorphous atorvastatin calcium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008514722A JP2008514722A (ja) | 2008-05-08 |
| JP2008514722A5 true JP2008514722A5 (enExample) | 2009-03-12 |
Family
ID=36143063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007534782A Pending JP2008514722A (ja) | 2004-09-30 | 2005-09-29 | 非結晶性アトルバスタチンカルシウム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080009540A1 (enExample) |
| EP (1) | EP1793815A4 (enExample) |
| JP (1) | JP2008514722A (enExample) |
| KR (1) | KR20070106680A (enExample) |
| CA (1) | CA2582449A1 (enExample) |
| TW (1) | TW200618795A (enExample) |
| WO (1) | WO2006039441A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009013633A2 (en) * | 2007-07-20 | 2009-01-29 | Actavis Group Ptc Ehf | Amorphous coprecipitates of atorvastatin pharmaceutically acceptable salts |
| EP2075246A1 (en) * | 2007-12-27 | 2009-07-01 | M. J. Institute of Research | A process for preparation of amorphous form of atorvastatin hemi-calcium salt |
| WO2009090544A2 (en) * | 2008-01-16 | 2009-07-23 | Matrix Laboratories Limited | Process for producing amorphous atorvastatin calcium |
| WO2010066687A2 (en) * | 2008-12-11 | 2010-06-17 | Dsm Ip Assets B.V. | Stabalized statin-comprising compositions |
| HUP1000299A2 (hu) | 2010-06-08 | 2012-02-28 | Nanoform Cardiovascular Therapeutics Ltd | Nanostrukturált Atorvastatint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra |
| IN2014CN04119A (enExample) | 2011-11-15 | 2015-07-10 | Reddys Lab Ltd Dr | |
| IN2015DN01445A (enExample) * | 2012-09-17 | 2015-07-03 | Dsm Sinochem Pharm Nl Bv | |
| WO2017042995A1 (ja) * | 2015-09-07 | 2017-03-16 | パナソニックIpマネジメント株式会社 | 車載用ステレオカメラ装置、およびその補正方法 |
| CN109280024A (zh) * | 2018-10-09 | 2019-01-29 | 河南师范大学 | 一种高纯度阿托伐他汀叔丁酯的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210840A (en) * | 1984-01-18 | 1987-05-29 | Johnson & Johnson Baby Prod | Composition comprising synergistic combination of miconazole nitrate and zinc oxide |
| HRP960312B1 (en) * | 1995-07-17 | 2001-10-31 | Warner Lambert Co | NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS /R-(R*, R*)/-2-(4-FLUOROPHENYL)-"beta", "delta"-DIHYDROXY-5-PHENYL-4-/(PHENYLAMINO)CARBONYL/-1H-PYRROLE -1-HEPTANOIC ACID CALCIUM SALT (2 : 1) |
| US6673374B2 (en) * | 1998-07-31 | 2004-01-06 | Howard Murad | Pharmaceutical compositions and methods for managing skin conditions |
| JP2002035579A (ja) * | 2000-07-24 | 2002-02-05 | Mitsubishi Gas Chem Co Inc | 水蒸気を吸収する脱酸素剤組成物 |
| US7501450B2 (en) * | 2000-11-30 | 2009-03-10 | Teva Pharaceutical Industries Ltd. | Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| IL156055A0 (en) * | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
| IN190564B (enExample) * | 2001-04-11 | 2003-08-09 | Cadila Heathcare Ltd | |
| AR038839A1 (es) * | 2002-02-14 | 2005-01-26 | Ranbaxy Lab Ltd | Formulacion de atorvastatina estabilizada con aditamentos de metales alcalinos. metodo para su elaboracion |
| JP4422488B2 (ja) * | 2002-02-19 | 2010-02-24 | テバ ファーマシューティカル インダストリーズ リミティド | アトルバスタチンヘミカルシウム溶媒和物の脱溶媒和法及び有機溶媒を本質的に含まないアトルバスタチンヘミカルシウム |
| SI21302A (sl) * | 2002-10-11 | 2004-04-30 | LEK farmacevtska dru�ba d.d. | Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino |
| US7655692B2 (en) * | 2003-06-12 | 2010-02-02 | Pfizer Inc. | Process for forming amorphous atorvastatin |
| US20050034599A1 (en) * | 2003-08-12 | 2005-02-17 | Takashi Nakata | Oxygen absorber composition, oxygen absorber packaging and oxygen absorption method |
| US7618953B2 (en) * | 2004-02-26 | 2009-11-17 | Zentiva, A.S. | Amorphous forms of risedronate monosodium |
| EP1761489A1 (en) * | 2004-03-17 | 2007-03-14 | Ranbaxy Laboratories Limited | Crystalline form of atorvastatin hemi calcium |
| DE602004032578D1 (de) * | 2004-03-19 | 2011-06-16 | Vb Medicare Pvt Ltd | Verbessertes verfahren zur herstellung von chlorierter saccharose |
-
2005
- 2005-09-29 US US11/576,396 patent/US20080009540A1/en not_active Abandoned
- 2005-09-29 WO PCT/US2005/035094 patent/WO2006039441A2/en not_active Ceased
- 2005-09-29 CA CA002582449A patent/CA2582449A1/en not_active Abandoned
- 2005-09-29 KR KR1020077007918A patent/KR20070106680A/ko not_active Ceased
- 2005-09-29 EP EP05803604A patent/EP1793815A4/en not_active Withdrawn
- 2005-09-29 JP JP2007534782A patent/JP2008514722A/ja active Pending
- 2005-09-30 TW TW094134218A patent/TW200618795A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100643971B1 (ko) | 건조 장치 및 그의 제조 방법 | |
| EP0943674B1 (en) | Oxygen absorbent composition | |
| JPH08325141A (ja) | 乾燥剤を含有する経皮薬物供給具 | |
| CN108271991A (zh) | 一种具备吸湿功能的食品用脱氧剂及其制备方法 | |
| AR047619A1 (es) | Producto farmaceutico estabilizado | |
| JP2008514722A (ja) | 非結晶性アトルバスタチンカルシウム | |
| TW200400065A (en) | Drug delivery assembly | |
| CN102989412A (zh) | 一种高效除湿剂 | |
| JPH02290220A (ja) | 板状乾燥剤 | |
| RU2419436C2 (ru) | Стабилизация тестостерона в устройствах чрескожного действия | |
| WO2001093859A1 (en) | Stable pharmaceutical product and formulation | |
| JP2002336693A (ja) | 酸素吸収剤組成物 | |
| US20070066578A1 (en) | 5-Aminosalicylic acid solid preparation improved in discoloration and method of storing the same | |
| JP3134291B2 (ja) | 酸素吸収用組成物 | |
| TH79580A (th) | อะทอร์วาสแตตินแคลเซียมอสัณฐาน | |
| CN100490941C (zh) | 一种干燥剂在活菌制剂干燥中的应用 | |
| CN1079766A (zh) | 一种高效防潮、防霉剂 | |
| WO2013093751A1 (en) | Packaging for linezolid | |
| JP2668888B2 (ja) | 酸素吸収剤 | |
| CN107876004A (zh) | 一种除湿剂 | |
| JPS6214940A (ja) | 脱酸素剤の製造法 | |
| JP2000005596A (ja) | 脱酸素剤 | |
| JPS609683B2 (ja) | 安定な農薬組成物の製造方法 | |
| JP2002138244A (ja) | 包装材料用塗料およびこれからなる塗膜を有する包装材料 | |
| CN101627755A (zh) | 1.3-二氯丙烯的固体剂型及其制法 |